Myeloma screening advances with research into identifying precursor conditions
Screening for SMM could guide treatment strategies for multiple myeloma, but identifying the right age cohort remains a challenge
By
Screening for SMM could guide treatment strategies for multiple myeloma, but identifying the right age cohort remains a challenge
ByIn order to improve diversity in trials, inequities due to economic factors and race need to be bridged at institutional…
ByWe've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
ByAn Iran-staged trial shows SpikoGen exceeded the 60% efficacy bar in the primary endpoint of prevention of symptomatic disease.
ByWe've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
ByCyanVac’s CVXGA1 is a nasally administered Covid-19 vaccine that uses a parainfluenza virus 5 vector.
ByWe've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
ByICON’s Tamie Joeckel discusses the challenges of making cell and gene therapies affordable for payers and patients alike.
By